In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis
about
Short chain fatty acids (butyrate) for induction of remission in ulcerative colitisHerbal medicine in the treatment of ulcerative colitisNutritional protective mechanisms against gut inflammationIncreasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot studyThe role of the colonic flora in maintaining a healthy large bowel mucosaOligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora.A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon.In vitro determination of prebiotic properties of oligosaccharides derived from an orange juice manufacturing by-product streamPathogenesis of colonic diverticula.Measurement of nutrition status in Crohn's disease patients receiving infliximab therapy.Review article: the role of nutrition in the treatment of inflammatory bowel disease.Impact of environmental and dietary factors on the course of inflammatory bowel disease.Importance of nutrition in inflammatory bowel disease.Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency.Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study.Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.The impact of date palm fruits and their component polyphenols, on gut microbial ecology, bacterial metabolites and colon cancer cell proliferation.Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: a randomized crossover trial.Nutritional modulation of the inflammatory response in inflammatory bowel disease--from the molecular to the integrative to the clinical.Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat.Substrate utilization by intestinal mucosal tissue strips from patients with inflammatory bowel disease.Butyrate and the cytokine-induced alpha1-proteinase inhibitor release in intestinal epithelial cells.Soluble fibers and resistant starch ameliorate disease activity in interleukin-10-deficient mice with inflammatory bowel disease.Dietary supplementation with beta-glucan enriched oat bran increases faecal concentration of carboxylic acids in healthy subjects.Pouchitis, similar to active ulcerative colitis, is associated with impaired butyrate oxidation by intestinal mucosa.The effect of sun-dried raisins (Vitis vinifera L.) on the in vitro composition of the gut microbiota.Tumor necrosis factor alpha reduces butyrate oxidation in vitro in human colonic mucosa: a link from inflammatory process to mucosal damage?Dietary Fermentable Fiber Reduces Intestinal Barrier Defects and Inflammation in Colitic Mice.Chicory increases acetate turnover, but not propionate and butyrate peripheral turnovers in rats.Macronutrient absorption characteristics in humans with short bowel syndrome and jejunocolonic anastomosis: starch is the most important carbohydrate substrate, although pectin supplementation may modestly enhance short chain fatty acid production aImpaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway*
P2860
Q24234780-BF4FC87A-5A1E-4002-9C02-8EC98B913AA3Q27022892-96DE5837-F1ED-4412-BD4B-50F0998EEC19Q27028202-B4850E40-8B5A-40CB-B6DB-49C195177462Q28206907-09F6C621-F19B-452C-AFEB-9C6A6EDA327DQ28363588-BCB6ACFC-9CD9-49AD-9E35-3B2FE9D32D8DQ34086638-B9CEAD21-B189-4882-9C1B-51A8CDE8C998Q34099033-6514D00A-8A80-453D-8F7E-6C2342A800CDQ34232328-DCA8B5C7-356E-454E-8A85-52133611DEA0Q34612205-5158E16D-C096-42F4-AD7D-6BFFFE457F28Q35659970-BB4803F5-7ED0-405B-9E6A-3597D0E5631CQ35880408-95502701-AF8A-48A3-AF31-BA0FFAD72669Q36144477-92AE8177-25D7-4664-9CEA-D3F7C210DA65Q37182945-CD31D2EE-1297-4602-9AEA-6092426369AAQ37602088-04BA10AE-3189-4E27-9C23-5ADC1865881DQ38832563-AD946E89-581B-4626-BEBF-102B0DC56C67Q40365232-AE32EE32-AF99-460C-81B1-5F5580463B4CQ40809300-AA8100BE-B858-44D5-B137-96B782F92655Q42043689-A913DA4F-BE7B-490B-99B5-8BA36024A7B5Q42704404-96B78D36-43B9-401F-835B-178E2722B79EQ43618399-CAA70AD9-B6DF-4E96-BA23-AE7D9FF28E72Q43669421-13A36617-A371-46EF-A60A-B314F45727F8Q43923370-67329F2F-BE73-47D8-9ED8-F7B5FC642669Q44400760-EE502B3A-D076-4845-BF8A-B63E54B863A8Q46264780-9E19498A-B7DD-4653-8C1A-73B2595B471BQ46303983-91D70376-B505-4712-8035-D170548A64B3Q46468676-E357FC76-B137-4DD2-89C7-6D2A94204925Q46500048-B15604D9-D2D9-41D7-900C-DBA123E0561CQ48365507-27148EA0-0378-4CA6-B377-61721E9930EDQ48386487-5ECE8541-1570-4273-AF7D-A4A8F99E26C7Q51496307-DA0646E4-F5FB-4A09-89BD-0C7DFB39FF8AQ57265340-849B87B2-531F-42FD-B577-223722C5E621
P2860
In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
In vivo measurement of colonic ...... h quiescent ulcerative colitis
@ast
In vivo measurement of colonic ...... h quiescent ulcerative colitis
@en
type
label
In vivo measurement of colonic ...... h quiescent ulcerative colitis
@ast
In vivo measurement of colonic ...... h quiescent ulcerative colitis
@en
prefLabel
In vivo measurement of colonic ...... h quiescent ulcerative colitis
@ast
In vivo measurement of colonic ...... h quiescent ulcerative colitis
@en
P2093
P2860
P356
P1433
P1476
In vivo measurement of colonic ...... h quiescent ulcerative colitis
@en
P2093
P2860
P356
10.1136/GUT.46.1.73
P407
P577
2000-01-01T00:00:00Z